TAO Synergies Inc.

TAOX Nasdaq CIK: 0001571934

Company Information

Industry Finance Services
SIC Code 6199
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Phone 9732420005
Fiscal Year End 1231
EIN 461585656

Financial Overview

FY2025

$10.96M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
5 Annual insider ownership changes February 5, 2026 View on SEC
S-3/A Shelf registration amendment January 2, 2026 View on SEC
8-K Current report of material events December 19, 2025 View on SEC
DEF 14A Definitive proxy statement November 17, 2025 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
S-3 Shelf registration for future offerings November 12, 2025 View on SEC
4 Insider stock transaction report October 17, 2025 View on SEC
4 Insider stock transaction report October 17, 2025 View on SEC
4 Insider stock transaction report October 17, 2025 View on SEC

Annual Reports

10-K March 31, 2026
  • Successful pivot from pharmaceutical research to a hybrid crypto-investment model focused on TAO tokens.
  • Raised $18 million in Q3 2025 through equity and warrant sales to fund operations and digital asset accumulation.
View Analysis

Related Companies

Companies in the same industry (SIC: 6199)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.